These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 8035924)

  • 21. White matter microstructural integrity and cognitive function in a general elderly population.
    Vernooij MW; Ikram MA; Vrooman HA; Wielopolski PA; Krestin GP; Hofman A; Niessen WJ; Van der Lugt A; Breteler MM
    Arch Gen Psychiatry; 2009 May; 66(5):545-53. PubMed ID: 19414714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertension in the elderly is associated with white matter lesions and cognitive decline.
    van Swieten JC; Geyskes GG; Derix MM; Peeck BM; Ramos LM; van Latum JC; van Gijn J
    Ann Neurol; 1991 Dec; 30(6):825-30. PubMed ID: 1789694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study.
    Longstreth WT; Arnold AM; Beauchamp NJ; Manolio TA; Lefkowitz D; Jungreis C; Hirsch CH; O'Leary DH; Furberg CD
    Stroke; 2005 Jan; 36(1):56-61. PubMed ID: 15569873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-related changes in white matter lesions, hippocampal atrophy, and cerebral microbleeds in healthy subjects without major cerebrovascular risk factors.
    Chowdhury MH; Nagai A; Bokura H; Nakamura E; Kobayashi S; Yamaguchi S
    J Stroke Cerebrovasc Dis; 2011; 20(4):302-9. PubMed ID: 20634092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. White matter lesions as a feature of cognitive impairment, low vitality and other symptoms of geriatric syndrome in the elderly.
    Sonohara K; Kozaki K; Akishita M; Nagai K; Hasegawa H; Kuzuya M; Yokote K; Toba K
    Geriatr Gerontol Int; 2008 Jun; 8(2):93-100. PubMed ID: 18713161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excellent cognitive performance despite massive cerebral white matter changes.
    Duning T; Kugel H; Knecht S
    Neuroradiology; 2005 Oct; 47(10):749-52. PubMed ID: 16151707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension and cerebral white matter lesions in a prospective cohort study.
    de Leeuw FE; de Groot JC; Oudkerk M; Witteman JC; Hofman A; van Gijn J; Breteler MM
    Brain; 2002 Apr; 125(Pt 4):765-72. PubMed ID: 11912110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cognitive impairment and cardiovascular disease risk factors. Project CASCADE Kraków. I. Project to test exposure to risk factors for cardiovascular disease in the studied sample].
    Pajak A; Kawalec E; Szczudlik A
    Przegl Lek; 1998; 55(12):676-82. PubMed ID: 10354721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study.
    Verdelho A; Madureira S; Ferro JM; Basile AM; Chabriat H; Erkinjuntti T; Fazekas F; Hennerici M; O'Brien J; Pantoni L; Salvadori E; Scheltens P; Visser MC; Wahlund LO; Waldemar G; Wallin A; Inzitari D;
    J Neurol Neurosurg Psychiatry; 2007 Dec; 78(12):1325-30. PubMed ID: 17470472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between hypertension, apoE, and cerebral white matter lesions.
    de Leeuw FE; Richard F; de Groot JC; van Duijn CM; Hofman A; Van Gijn J; Breteler MM
    Stroke; 2004 May; 35(5):1057-60. PubMed ID: 15060316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional variability in the prevalence of cerebral white matter lesions: an MRI study in 9 European countries (CASCADE).
    Launer LJ; Berger K; Breteler MM; Dufouil C; Fuhrer R; Giampaoli S; Nilsson LG; Pajak A; de Ridder M; van Dijk EJ; Sans S; Schmidt R; Hofman A
    Neuroepidemiology; 2006; 26(1):23-9. PubMed ID: 16254450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. White matter hyperintensity signals in psychiatric and nonpsychiatric subjects.
    Brown FW; Lewine RJ; Hudgins PA; Risch SC
    Am J Psychiatry; 1992 May; 149(5):620-5. PubMed ID: 1575251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study.
    van Dijk EJ; Breteler MM; Schmidt R; Berger K; Nilsson LG; Oudkerk M; Pajak A; Sans S; de Ridder M; Dufouil C; Fuhrer R; Giampaoli S; Launer LJ; Hofman A;
    Hypertension; 2004 Nov; 44(5):625-30. PubMed ID: 15466662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Higher blood-brain barrier permeability is associated with higher white matter hyperintensities burden.
    Li Y; Li M; Zhang X; Shi Q; Yang S; Fan H; Qin W; Yang L; Yuan J; Jiang T; Hu W
    J Neurol; 2017 Jul; 264(7):1474-1481. PubMed ID: 28653212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2.
    Lopez OL; Jagust WJ; Dulberg C; Becker JT; DeKosky ST; Fitzpatrick A; Breitner J; Lyketsos C; Jones B; Kawas C; Carlson M; Kuller LH
    Arch Neurol; 2003 Oct; 60(10):1394-9. PubMed ID: 14568809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly.
    Bakker SL; de Leeuw FE; de Groot JC; Hofman A; Koudstaal PJ; Breteler MM
    Neurology; 1999 Feb; 52(3):578-83. PubMed ID: 10025791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral white matter lesions in patients with cirrhosis - causative for hepatic encephalopathy or bystanders?
    Pflugrad H; Bronzlik P; Raab P; Tryc AB; Goldbecker A; Barg-Hock H; Strassburg CP; Ding XQ; Lanfermann H; Weissenborn K
    Liver Int; 2015 Jul; 35(7):1816-23. PubMed ID: 25546380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TGF-beta1 is associated with the progression of intracranial deep white matter lesions: a pilot study with 5 years of magnetic resonance imaging follow-up.
    Kuriyama N; Mizuno T; Kita M; Yamada K; Ozaki E; Matsumoto S; Takada A; Watanabe A; Kasai T; Nagakane Y; Mitani S; Matsui D; Watanabe I; Takeda K; Nakagawa M; Watanabe Y
    Neurol Res; 2014 Jan; 36(1):47-52. PubMed ID: 24083683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. White Matter Lesions: Prevalence and Clinical Phenotype in Asymptomatic Individuals Aged ≥50 Years.
    David JP; Ferrat E; Parisot J; Naga H; Lakroun S; Menasria F; Saddedine S; Natella PA; Paillaud E; Fromentin I; Bastuji-Garin S
    Dement Geriatr Cogn Disord; 2016; 42(3-4):159-168. PubMed ID: 27649085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased plasma tryptophan associated with deep white matter lesions in elderly subjects.
    Yao H; Yuzuriha T; Koga H; Fukuda K; Endo K; Matsumoto T; Kato A; Uchino A; Ezaki T; Ibayashi S; Uchimura H; Fujishima M
    J Neurol Neurosurg Psychiatry; 1999 Jan; 66(1):100-3. PubMed ID: 9886464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.